Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04813601
Other study ID # ATLAS2030CLI-I
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 9, 2020
Est. completion date September 24, 2023

Study information

Verified date October 2023
Source MarsiBionics
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this multicentric study is to assess the rehabilitative effect derived from the use of the ATLAS exoskeleton in children with neuromuscular diseases or cerebral palsy and with a level of less than 3 or less in the Functional Ambulation Classification (FAC) as a consequence of their disease, as well as the assessment of other physical, functional and quality of life parameters of interest. For this purpose, the exoskeleton will be used as a rehabilitation and walking assistance tool. Before starting the study programme and if deemed necessary, a preliminary phase consisting of 1 to 3 sessions will be carried out during which the patient will be shown the exoskeleton for the first time and it will be considered whether any improvements to the different parts of the device or the software are necessary to increase the ergonomics and comfort of the patient.


Description:

The objectives of the study are: - Objective 1: To assess the safety and physical and physiological tolerance of the child to the activity performed with the exoskeleton in the rehabilitation sessions. - Objective 2: - To assess the safety of a progressive treatment algorithm to achieve the safe progression of patients throughout the therapy - To assess whether an improvement is achieved in parameters related to the physical rehabilitation of the patient using the exoskeleton, in respiratory capacity, self-perceived quality of life (physical and emotional well-being and self-esteem) as well as to assess the effectiveness of a psychological intervention to provide support in coping with the situation of using the device for the first time in those children who have not used it before. The time period of the study will be as long as necessary to reach the desired number of participants, in this case 10 children (N=10). The participants will be patients affected by neuromuscular diseases or cerebral palsy and will be selected on the basis of the following inclusion/exclusion criteria: Inclusion criteria: 1. Children with neuromuscular disease or cerebral palsy who present gait disturbances or no gait disturbance. 2. Children between 3 and 11 years of age. Exclussion criteria: not fulfil the usage criteria of the device.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date September 24, 2023
Est. primary completion date March 9, 2021
Accepts healthy volunteers No
Gender All
Age group 3 Years to 14 Years
Eligibility Inclusion Criteria: - Children with neuromuscular disease or cerebral palsy who have gait disturbance or no gait. - Children between 3 and 14 years of age. Exclusion Criteria: - Weight> 35 kg - Femoral length (from the axis of the hip joint in the sagittal plane to the axis of the knee joint in the same plane) <23 cm or >38 cm for size M and from 31 cm to 40 cm for size L - Stem length (from the axis of the knee joint in the sagittal plane to the axis of the ankle joint in the same plane) <23 or >32 cm for size M and from or >39 cm for size L - Distance between great trochanters <24 or >35 cm for size M and <25 cm or >35 cm for size L - Inability to understand simple commands, to cooperate actively in therapy, or inability to express basic needs - Spasticity measured with the Modified Ashworth Scale greater than or equal to 3 in the lower limbs - Scoliosis > 25° without the possibility of wearing a brace - Skin alteration where direct contact between the patient's skin and the exoskeleton is not recommended - Limitation of passive range of motion at the knee or hip joint > 20 degrees - Osteoporosis that may induce a bone fracture when low intensity physical activity is performed - Any other medical condition that may be a risk to the patient's safety and well-being in relation to low intensity physical exercise

Study Design


Related Conditions & MeSH terms


Intervention

Device:
ATLAS 2030
The participant will attend the laboratory every week, two days a week. The therapy will consist of the use of the exoskeleton for rehabilitative purposes. At the end of each three-month period, each patient's data will be monitored.

Locations

Country Name City State
Spain MarsiCare Arganda Del Rey Madrid

Sponsors (3)

Lead Sponsor Collaborator
MarsiBionics Hospital Universitario La Paz, National Research Council, Spain

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Muscular balance Strength measured in Newtons with a Hand-Held Dinamometer for elbow flexion, neck lateralization, ankle plantarflexion and dorsiflexion, knee flexion and extension. 1 month
Primary Expanded Hammersmith Functional Motor Scale Motor functionality measured for children with Spinal Muscular Atrophy 3 months
Primary Gross Motor Function Measure 88 (GMFM-88) Motor functionality measured for children with Cerebral Palsy. 3 months
Primary Respiratory rate Respiratory rate measured manually in breaths per minute using chronometer 1 day
Primary Heart rate Measured in beats per minute using vital sign monitor 1 day
Primary Oxigen Saturation Measured in %O2 using vital sign monitor 1 day
Primary Blood preasure measured in mmHg with a sphyngomanometer 1 day
Primary Respiratory functional parameters Measured by Spirometer (volumes measured in litres and pressures in mmHg) 3 months
Primary Quality of life assessment Quality of life iof the children measured using the KINDL questionnaire. 3 months
Primary Joint range of motion Range of motion in degrees of hip, knee and ankle movements using a manual goniometer. 1 month
Primary Revised Upper Limb Module (RULM) Upper limb quality of movement using RULM scale for Spinal Muscular Atrophy children 3 months
Primary Quality Upper Extremity Skill test (QUEST) Upper limb quality of movement using QUEST scale for cerebral palsy children 3 months
Primary The Functional Independence Measure for Children (WeeFim) WeeFim scale for CP children. 3 months
Primary Egen Klassifikation Functional ability measured using EK2 scale for SMA 3 months
Primary Skin integrity Skin alterations assessing their localization, size (centimeters), redness and temperature increase. 1 day
Primary Fatigue Patient fatigue measured by Borg fatigue scale for children ages 1 day
Primary Pain assessment Patient pain measured by EVA faces scale for children ages 1 day
Primary Peak Flow cough Measured in litres per minute using a Peak flowmeter 1 week
See also
  Status Clinical Trial Phase
Recruiting NCT05317234 - Genetic Predisposition in Cerebral Palsy N/A
Recruiting NCT05576948 - Natural History of Cerebral Palsy Prospective Study
Completed NCT04119063 - Evaluating Wearable Robotic Assistance on Gait Early Phase 1
Completed NCT03264339 - The Small Step Program - Early Intervention for Children With High Risk of Developing Cerebral Palsy N/A
Completed NCT05551364 - Usability and Effectiveness of the ATLAS2030 Exoskeleton in Children With Cerebral Palsy N/A
Completed NCT03902886 - Independent Walking Onset of Children With Cerebral Palsy
Recruiting NCT05571033 - Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy N/A
Not yet recruiting NCT04081675 - Compliance in Children With Cerebral Palsy Supplied With AFOs
Completed NCT02167022 - Intense Physiotherapies to Improve Function in Young Children With Cerebral Palsy N/A
Completed NCT04012125 - The Effect of Flexible Thoracolumbar Brace on Scoliosis in Cerebral Palsy N/A
Enrolling by invitation NCT05619211 - Piloting Movement-to-Music With Arm-based Sprint-Intensity Interval Training Among Children With Physical Disabilities Phase 1
Completed NCT04489498 - Comparison of Somatometric Characteristics Between Cerebral Palsy and Normal Children, Cross-sectional, Multi Center Study
Completed NCT03677193 - Biofeedback-enhanced Interactive Computer-play for Youth With Cerebral Palsy N/A
Recruiting NCT06450158 - Robot-assisted Training in Children With CP N/A
Completed NCT04093180 - Intensive Neurorehabilitation for Cerebral Palsy N/A
Completed NCT02909127 - The Pediatric Eating Assessment Tool
Not yet recruiting NCT06377982 - Human Umbilical Cord Blood Infusion in Patients With Cerebral Palsy Phase 1
Not yet recruiting NCT06007885 - Examining Capacity Building of Youth With Physical Disabilities to Pursue Participation Following the PREP Intervention. N/A
Not yet recruiting NCT03183427 - Corpus Callosum Size in Patients With Pineal Cyst N/A
Active, not recruiting NCT03078621 - Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy Phase 1/Phase 2